You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NTLA Award Disclosure
Goodman Jesse · SEC Form 4 · Filed Jun 10, 2026
Award
Calculated transaction value
$0
Goodman Jesse Director
NTLA
Transaction date
Jun 9, 2026
Public filing date
Jun 10, 2026
Filing lag
Filed 1 day later
NTLA daily price context
Close on/before transaction
$12.89
Jun 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 13,300 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001756929-26-000002
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Intellia Therapeutics, Inc. NTLA | Award | Jun 9, 2026 | $0 |
| Intellia Therapeutics, Inc. NTLA Current | Award | Jun 9, 2026 | $0 |